MADISON â?? For people who suffer from epilepsy, current drugs donâ??t always control seizures. A startup company with ties to UW-Madison technology, NeuroGenomex Inc., is trying to provide a breakthrough medication.
Epilepsy affects more than 3 million Americans every year, with most new cases developing in children and elderly. Epilepsy is a central nervous system disorder whose main symptom is seizure caused by electric activity in the brain.